Guru Ownership Trend
Guru Analysis for UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. (URGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $51.17 M.
Top institutional holders include Jefferies Group and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.03 M net outflow during the quarter.
On the selling side, Cliff Asness reduced exposure by 24.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for UroGen Pharma Ltd. (URGN)
Major holders include Jefferies Group ($51.52 M), Renaissance Technologies (RenTech) ($5.72 M), Cliff Asness ($3.59 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.72 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.03 M, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited URGN. The total reported sell value was $2.03 M.
No tracked managers opened new positions or increased their holdings in URGN during the most recent reporting period.